Looking to publish in Therapeutic Advances in Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginTherapeutic Advances in Hematology is a peer-reviewed open access journal with a strong clinical and pharmacological focus aimed at clinicians and researchers in hematology.
Looking to publish in Therapeutic Advances in Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Therapeutic Advances in Hematology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
General Reviews
Perspective Reviews
Drug Reviews
Systematic Reviews
Meta-Analyses
Registered Reports – Pre-Data
Registered Reports – Post-Data
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
The impact of chemotherapy relative dose intensity on survival in elderly patients with extranodal NK/T-cell lymphoma: A retrospective cohort study
Wanyue Zhao, Siyu Qian, Yuxiao Chang, Wenjie Gu, Shuchang Li, Shifeng Hao, Xiang Gao, Suxiao Li, Meng Dong, Qingjiang Chen, Lu Zhao, Xudong Zhang
Hypoplastic acute myeloid leukemia with aberrant lymphoid antigen expression and EWSR1::FEV fusion: A rare case report and literature review
Wenxia Xia, Junyan Zou, Xiaoyong Chen, Jing Luo, Chun Feng, Mao Dai, Yanhong Ding, Jihao Zhou, Peng Ke, Huijun Li, Junjie Hou
Identification of novel UBE2E3::PDE1A and CTC1::MEF2C fusion transcripts in acute myeloid leukemia
Jifang Tu, Yungui Wang, Xiangli Gao, Huanping Wang, Huafeng Wang, Jie Jin, Hongyan Tong
Romiplostim during pregnancy in refractory primary immune thrombocytopenia: Literature review and case series
Dina Weinstein Mezan, Efrat Shekel, Batia Roth, Yosef Kalish, Doron Kabiri
Immune and cytokine landscape differs between cytopenic and proliferative phenotypes in primary myelofibrosis
Sze-Hwei Lee, Yu-Hung Wang, Yu-Sung Chang, Chao-Hung Wei, Chang-Tsu Yuan, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Chien-Chin Lin
Frequently asked questions
How long does it take to publish?
Accepted articles can appear online within an average of 30 days after APC processing.
Reformat to Therapeutic Advances in Hematology using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should explain why the manuscript is suitable for publication and, if fast-track publication is requested, explain why.
Reformat to Therapeutic Advances in Hematology using Livewrite PremiumWhat are the publication costs?
Article processing charges apply for hybrid open access journals. Institutional agreements, prepaid accounts, or affiliation-based discounts may help cover APCs.
Reformat to Therapeutic Advances in Hematology using Livewrite Premium